Skin and thigh muscle metastasis from papillary thyroid cancer

Singapore Medical Journal

Volumn 50, Issue 2, 2009, Pages

  Bruglia, M ^a   Palmonella, G ^a   Silvetti, F ^a   Rutigliano, P ^a   Criante, P ^b   Marmorale, C ^c   Boscaro, M ^a   Taccaliti, A ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Institute of Pathology

^c Institute of Surgery

Author keywords

Papillary thyroid carcinoma; Skin metastasis; Thigh metastasis; Thyroglobulin; Thyroid cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; IODINE 131; RECOMBINANT THYROTROPIN; THYROGLOBULIN;

ADULT; ARTICLE; BICEPS FEMORIS MUSCLE; BRAIN METASTASIS; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CASE REPORT; COMBINATION CHEMOTHERAPY; CORPUS CALLOSUM; EXTERNAL BEAM RADIOTHERAPY; HEADACHE; HUMAN; LYMPH NODE ENLARGEMENT; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHADENOPATHY; MALE; MEDIASTINUM METASTASIS; MUSCLE; MUSCLE METASTASIS; PAIN; PAPILLARY THYROID CANCER; SKIN METASTASIS; THIGH; THIGH MUSCLE METASTASIS; THYROID CANCER; THYROIDECTOMY; TUMOR BIOPSY; TUMOR GROWTH; WHOLE BODY SCINTISCANNING;

ADULT; BIOPSY; CARCINOMA, PAPILLARY; FATAL OUTCOME; HUMANS; LUNG NEOPLASMS; MALE; MEDIASTINAL NEOPLASMS; MUSCLE, SKELETAL; NEOPLASM METASTASIS; RADIOTHERAPY; SKIN NEOPLASMS; THIGH; THYROGLOBULIN; THYROID NEOPLASMS;

EID: 63449103054     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Sakamoto A. Definition of poorly differentiated carcinoma of the thyroid: the Japanese experience. Endocr Pathol 2004; 15:307-11.
2. Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H. Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol 1999; 23:205-11.
3. Pacini F, Schlumberger M, Dralle E, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154:787-803. Erratum in: Eur J Endocrinol 2006; 155:385.
4. Jukkola A, Bloiqu R, Ebeling T, Salmela P, Blanco G. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 2004; 11:571-9.
5. Nikiforova MN, Kimura ET, Gandhi M, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 2003; 88:5399-404.
6. Haq M, Harmer C. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol (Oxf) 2005; 63:87-93.
7. Pacak K, Eisenhofer G, Goldstein DS. Functional imaging of endocrine tumors: role of positron emission tomography. Endocr Rev 2004; 25:568-80.
8. Patel KN, Shaha AR. Poorly differentiated and anaplastic thyroid cancer. Cancer Control 2006; 13:119-28.
9. Iwai H, Ohno Y, Ito H, Kiyokawa T, Aoki N. Renal rupture associated with a poorly differentiated follicular thyroid carcinoma metastasizing to the thigh muscle, lung and kidney. Intern Med 2005; 44:848-52.
10. Lam KY, Lo CY, Chan KW, Wan KY. Insular and anaplastic carcinoma of the thyroid. A 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 2000; 231:329-38.
11. Dobashi Y, Sakamoto A, Sugimura H, et al. Overexpression of p53 as a possible diagnostic factor in human thyroid carcinoma. Am J Surg Pathol 1993; 17:375-81.
12. Hassan I, Wunderlich A, Burchert A, Hoffmann S, Zielke A. Antisense p53 oligonucleotides inhibit proliferation and induce chemosensitivity in follicular thyroid cancer cells. Anticancer Res 2006; 26:1171-6.
13. Malaguarnera R, Vella V, Vigneri R, Frasca F. p53 family proteins in thyroid cancer. Endocr Relat Cancer 2007; 14:43-60.
14. Alzahrani AS, Mohamed G, Al Shammary A, et al. Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer. J Endocrinol Invest 2005; 28:540-6.
15. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16:109-42.